PCN151 HTAs for the Deadliest Diseases: What Can We Learn From Multi-National Comparisons of Oncology and Cardiology Health Technology Assessments?

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.2191
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Unexpected Deaths in Cardiology Outpatients – What Can We Learn From Case Review?

JRSM Open
2016English

What Can We Learn From China’s Health System Reform?

British Medical Journal
Medicine
2019English

What Can We Learn From Liver?

2016English

The Health Returns to Education - What Can We Learn From Twins?

SSRN Electronic Journal
2008English

What Can We Learn From the Fascia Congress?

Journal of Bodywork and Movement Therapies
ComplementaryPhysical TherapyManual TherapyAlternative MedicineSports TherapyRehabilitation
2008English

What Can We Learn From Bobtail Squid?

2019English

What Can We Learn From Numerical Data?

Cardiology in the Young
PediatricsCardiologyPerinatologyCardiovascular MedicineMedicineChild Health
2000English

Use of Surrogate Outcomes in Health Technology Assessments (HTAs)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Neurosecretion: What Can We Learn From Chromaffin Cells

Pflugers Archiv European Journal of Physiology
Clinical BiochemistryPhysiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy